Hepatoprotective effect of oleuropein in mice: Mechanisms uncovered by gene expression profiling

Biotechnology Journal

Volumn 5, Issue 9, 2010, Pages 950-960

  Kim, Yunjung ^a   Choi, Youngshim ^a   Park, Taesun ^a  

^a Yonsei University   (South Korea)

Author keywords

Microarray; Molecular mechanism; Non alcoholic fatty liver; Nutrigenomics; Oleuropein

Indexed keywords

BENEFICIAL EFFECTS; DNA MICROARRAY ANALYSIS; GAIN INSIGHT; GENE EXPRESSION PROFILING; HEPATIC GENES; HEPATIC TISSUE; HEPATOPROTECTIVE; HIGH-FAT DIET; IN-VIVO; INSULIN RESISTANCE; KEY REGULATORS; LIPID PEROXIDATION; LIPOGENESIS; MOLECULAR MECHANISM; MRNA LEVEL; NON-ALCOHOLIC FATTY LIVER; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRIGENOMICS; OLEUROPEIN; OLIVE LEAF; OXIDATIVE STRESS RESPONSE; PHARMACOLOGICAL ACTIVITY; PROINFLAMMATORY CYTOKINES; PROTECTIVE EFFECTS; SCAVENGE REACTIVE OXYGEN SPECIES; TARGET GENES;

CELL PROLIFERATION; DETOXIFICATION; FATTY ACIDS; GENES; LIVER; OXYGEN; TRANSCRIPTION FACTORS;

TRANSCRIPTION;

CYTOKINE; OLEUROPEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CONTROLLED STUDY; DETOXIFICATION; DRUG MECHANISM; FATTY ACID TRANSPORT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; LIPID DIET; LIPID PEROXIDATION; LIPOGENESIS; LIVER PROTECTION; MALE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRIGENOMICS; OLIVE; OXIDATIVE STRESS; PLANT LEAF; PRIORITY JOURNAL; PROMOTER REGION; UNINDEXED SEQUENCE;

ANIMALS; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LIPID METABOLISM; LIVER; MALE; MICE; MICE, INBRED C57BL; NUTRIGENOMICS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PYRANS; TRANSCRIPTION FACTORS;

MUS;

EID: 77956564923     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201000068     Document Type: Article

References (60)

1. Wolfram, S., Raederstorff, D., Preller, M., Wang, Y. et al., Epigallocatechin gallate supplementation alleviates diabetes in rodents. J. Nutr. 2006, 136, 2512-2518. (Pubitemid 44521606)
2. Klaus, S., Pultz, S., Thone-Reineke, C., Wolfram, S., Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. Int. J. Obes. (Lond) 2005, 29, 615-623. (Pubitemid 40769483)
3. Whyte, L., Huang, Y. Y., Torres, K., Mehta, R. G., Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007, 67, 12007-12017.
4. Rahman, K. W., Li, Y., Wang, Z., Sarkar, S. H., Sarkar, F. H., Gene expression profiling revealed survivin as a target of 3,3′- diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells. Cancer Res. 2006, 66, 4952-4960.
5. Andreadou, I., Iliodromitis, E. K., Mikros, E., Constantinou, M. et al., The olive constituent oleuropein exhibits anti-ischemic, antioxidative, and hypolipidemic effects in anesthetized rabbits. J. Nutr. 2006, 136, 2213-2219. (Pubitemid 44156827)
6. Bitler, C. M., Viale, T. M., Damaj, B., Crea, R., Hydrolyzed olive vegetation water in mice has anti-inflammatory activity. J. Nutr. 2005, 135, 1475-1479. (Pubitemid 40799613)
7. Hamdi, H. K., Castellon, R., Oleuropein, a non-toxic olive iridoid, is an anti-tumor agent and cytoskeleton disruptor. Biochem. Biophys. Res. Commun. 2005, 334, 769-778. (Pubitemid 41033188)
8. Al-Azzawie, H. F., Alhamdani, M. S., Hypoglycemic and antioxidant effect of oleuropein in alloxan-diabetic rabbits. Life Sci. 2006, 78, 1371-1377. (Pubitemid 43199957)
9. Oi-Kano, Y., Kawada, T., Watanabe, T., Koyama, F. et al., Oleuropein, a phenolic compound in extra virgin olive oil, increases uncoupling protein 1 content in brown adipose tissue and enhances noradrenaline and adrenaline secretions in rats. J. Nutr. Sci. Vitaminol. (Tokyo) 2008, 54, 363-370.
10. Omagari, K., Kato, S., Tsuneyama, K., Hatta, H. et al., Olive leaf extract prevents spontaneous occurrence of non-alcoholic steatohepatitis in SHR/NDmcr-cp rats. Pathology 2010, 42, 66-72.
11. Poudyal, H., Campbell, F., Brown, L., Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J. Nutr. 2010, 140, 946-953.
12. Kim, Y. J., Park, T., Genes are differentially expressed in the epididymal fat of rats rendered obese by a high-fat diet. Nutr. Res. 2008, 28, 414-422. (Pubitemid 351718477)
13. Folch, J., Lees, M., Sloane Stanley, G. H., A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957, 226, 497-509.
14. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D. et al., Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000, 25, 25-29.
15. Reddy, J. K., Mannaerts, G. P., Peroxisomal lipid metabolism. Annu. Rev. Nutr. 1994, 14, 343-370.
16. Musso, G., Gambino, R., Cassader, M., Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 2009, 48, 1-26.
17. Robertson, G., Leclercq, I., Farrell, G. C., Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G1135-1139.
18. Browning, J. D., Horton, J. D., Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004, 114, 147-152. (Pubitemid 39071617)
19. Koonen, D. P., Jacobs, R. L., Febbraio, M., Young, M. E. et al., Increased hepatic CD36 expression contributes to dyslipidemia associated with diet-induced obesity. Diabetes 2007, 56, 2863-2871.
20. Luiken, J. J., Arumugam, Y., Dyck, D. J., Bell, R. C. et al., Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats. J. Biol. Chem. 2001, 276, 40567-40573.
21. Zhou, J., Febbraio, M., Wada, T., Zhai, Y. et al., Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 2008, 134, 556-567.
22. Makowski, L., Hotamisligil, G. S., The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis. Curr. Opin. Lipidol. 2005, 16, 543-548. (Pubitemid 41376904)
23. Wolfrum, C., Borrmann, C. M., Borchers, T., Spener, F., Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus. Proc. Natl. Acad. Sci. USA 2001, 98, 2323-2328.
24. Tanaka, A. R., Tanabe, K., Morita, M., Kurisu, M. et al., ATP binding/hydrolysis by and phosphorylation of peroxisomal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1). J. Biol. Chem. 2002, 277, 40142-40147.
25. Kim, S., Sohn, I., Ahn, J. I., Lee, K. H., Lee, Y. S., Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004, 340, 99-109. (Pubitemid 39360236)
26. Kim, Y., Park, T., DNA microarrays to define and search for genes associated with obesity. Biotechnol. J. 2010, 5, 99-112.
27. Visioli, F., Bellomo, G., Galli, C., Free radical-scavenging properties of olive oil polyphenols. Biochem. Biophys. Res. Commun. 1998, 247, 60-64.
28. Visioli, F., Bellomo, G., Montedoro, G., Galli, C., Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 1995, 117, 25-32.
29. Bohmann, D., Transcription factor phosphorylation: A link between signal transduction and the regulation of gene expression. Cancer Cells 1990, 2, 337-344.
30. Ouyang, J., Valin, A., Gill, G., Regulation of transcription factor activity by SUMO modification. Methods Mol. Biol. 2009, 497, 141-152.
31. Gavrilova, O., Haluzik, M., Matsusue, K., Cutson, J. J. et al., Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J. Biol. Chem. 2003, 278, 34268-34276.
32. Matsusue, K., Gavrilova, O., Lambert, G., Brewer, H. B., Jr. et al., Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Mol. Endocrinol. 2004, 18, 2751-2764. (Pubitemid 39482063)
33. Jump, D. B., Botolin, D., Wang, Y., Xu, J. et al., Fatty acid regulation of hepatic gene transcription. J. Nutr. 2005, 135, 2503-2506.
34. Letexier, D., Pinteur, C., Large, V., Frering, V., Beylot, M., Comparison of the expression and activity of the lipogenic pathway in human and rat adipose tissue. J. Lipid Res. 2003, 44, 2127-2134.
35. Cui, Y., Hosui, A., Sun, R., Shen, K. et al., Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration. Hepatology 2007, 46, 504-513.
36. Blaas, L., Kornfeld, J. W., Schramek, D., Musteanu, M. et al., Disruption of the growth hormone-signal transducer and activator of transcription 5-insulin-like growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis. Hepatology 2010, 51, 1319-1326.
37. Wang, X. L., Suzuki, R., Lee, K., Tran, T. et al., Ablation of ARNT/HIF1beta in liver alters gluconeogenesis, lipogenic gene expression, and serum ketones. Cell Metab. 2009, 9, 428-439.
38. Hayhurst, G. P., Lee, Y. H., Lambert, G., Ward, J. M., Gonzalez, F. J., Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 2001, 21, 1393-1403. (Pubitemid 32114986)
39. Kim, J. W., Monila, H., Pandey, A., Lane, M. D., Upstream stimulatory factors regulate the C/EBP alpha gene during differentiation of 3T3-L1 preadipocytes. Biochem. Biophys. Res. Commun. 2007, 354, 517-521.
40. Kim, J. K., Fat uses a TOLL-road to connect inflammation and diabetes. Cell Metab. 2006, 4, 417-419.
41. Wymann, M. P., Schneiter, R., Lipid signalling in disease. Nat. Rev. Mol. Cell Biol. 2008, 9, 162-176.
42. Matsuguchi, T., Masuda, A., Sugimoto, K., Nagai, Y., Yoshikai, Y., JNK-interacting protein 3 associates with Toll-like receptor 4 and is involved in LPS-mediated JNK activation. EMBO J. 2003, 22, 4455-4464.
43. Robinson, K., Vona-Davis, L., Riggs, D., Jackson, B., McFadden, D., Peptide YY attenuates STAT1 and STAT3 activation induced by TNF-alpha in acinar cell line AR42J. J. Am. Coll. Surg. 2006, 202, 788-796.
44. dela Paz, N. G., Simeonidis, S., Leo, C., Rose, D. W., Collins, T., Regulation of NF-kappaB-dependent gene expression by the POU domain transcription factor Oct-1. J. Biol. Chem. 2007, 282, 8424-8434.
45. Rosen, E. D., MacDougald, O. A., Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7, 885-896.
46. Herzig, S., Long, F., Jhala, U. S., Hedrick, S. et al., CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413, 179-183. (Pubitemid 32867880)
47. Liu, Y., Nakagawa, Y., Wang, Y., Liu, L. et al., Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J. Mol. Endocrinol. 2008, 41, 53-64.
48. Hanley, K. P., Oakley, F., Sugden, S., Wilson, D. I. et al., Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J. Biol. Chem. 2008, 283, 14063-14071.
49. Michl, P., Downward, J., CUTL1: A key mediator of TGFbeta-induced tumor invasion. Cell Cycle 2006, 5, 132-134.
50. Goyama, S., Yamamoto, G., Shimabe, M., Sato, T. et al., Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells. Cell Stem Cell 2008, 3, 207-220.
51. Buckingham, M., Relaix, F., The role of Pax genes in the development of tissues and organs: Pax3 and Pax7 regulate muscle progenitor cell functions. Annu. Rev. Cell Dev. Biol. 2007, 23, 645-673.
52. Somm, E., Schwitzgebel, V. M., Vauthay, D. M., Camm, E. J. et al., Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 2008, 149, 6289-6299.
53. Gearing, K. L., Gottlicher, M., Teboul, M., Widmark, E., Gustafsson, J. A., Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA 1993, 90, 1440-1444.
54. Law, I. K., Xu, A., Lam, K. S., Berger, T. et al., Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010, 59, 872-882.
55. Ventre, J., Doebber, T., Wu, M., MacNaul, K. et al., Targeted disruption of the tumor necrosis factor-alpha gene: Metabolic consequences in obese and nonobese mice. Diabetes 1997, 46, 1526-1531.
56. Jemai, H., El Feki, A., Sayadi, S., Antidiabetic and antioxidant effects of hydroxytyrosol and oleuropein from olive leaves in alloxan-diabetic rats. J. Agric. Food Chem. 2009, 57, 8798-8804.
57. Canon, E., Cosgaya, J. M., Scsucova, S., Aranda, A., Rapid effects of retinoic acid on CREB and ERK phosphorylation in neuronal cells. Mol. Biol. Cell 2004, 15, 5583-5592. (Pubitemid 39564749)
58. Dentin, R., Hedrick, S., Xie, J., Yates, J., 3rd, Montminy, M., Hepatic glucose sensing via the CREB coactivator CRTC2. Science 2008, 319, 1402-1405.
59. Sirianni, R., Chimento, A., De Luca, A., Casaburi, I. et al., Oleuropein and hydroxytyrosol inhibit MCF-7 breast cancer cell proliferation interfering with ERK1/2 activation. Mol. Nutr. Food Res. 2009, 54, 833-840.
60. Yunoki, K., Sasaki, G., Tokuji, Y., Kinoshita, M. et al., Effect of dietary wine pomace extract and oleanolic acid on plasma lipids in rats fed high-fat diet and its DNA microarray analysis. J. Agric. Food Chem. 2008, 56, 12052-12058.